The major problem of total parenteral treatment consists in the balancing of the source and dose of the nutritional mixture, so as to not deepen malnutrition with a positive impact on the patients' organism. the aim of the study was to evaluate selected factors that induce hepato-billiary complications in patients treated by means of parenteral nutrition at home. material and methods. The retrospective study comprised 70 patients with biochemistry performed every three months. Considering statistical analysis patients were allocated to four groups, depending on the period of treatment. Group A analysis results were based on the activity of aminotransferases, group B on the activity of bilirubin. Both groups A and B were additionally divided into group I where we assigned normal values of control lab results, and group II with improper results after treatment. Results. Differences between groups Ia vs IIa were presented on the basis of the daily supply of glucose: mean-2.52 vs 3.49 g/kg (p=0.000003), glucose/lipids ratio: mean-3.76 vs 4.90 g/kg (p=0.0001), daily non-protein energy: mean-16.73 vs 21.06 kcal/kg (p=0.0001). Differences between groups Ib vs IIb were presented on the basis of the daily supply of glucose: mean-2.76 vs 3.46 g/kg (p=0.0007), glucose/lipids ratio: mean-3.98 vs 5.13 g/kg (p=0.01), daily non-protein energy: mean-17.96 vs 20.36 kcal/kg (p=0.04). Based on the above-mentioned analysis the main goal in the prevention of hepatic complications should lead to the reduction of the dose of glucose. Increased glucose supply leads to increased number of hepato-billiary complications. conclusions. Based on obtained results we were able to conclude that in case of liver complications associated with parenteral nutrition, proper management consists in the modification of nutritional mixtures (reduction in the daily glucose supply and change in the proportions of extra-protein energy). Such management has the greatest clinical effect. When determining the composition of the nutritional mixture one should adjust the glucose supply, so as to offset both sources of extra-protein energy
Total parenteral nutrition (TPN) at home is a therapy designed at feeding the patient parenterally, different from the standard physiological manner (1) . The above-mentioned therapy enables to survive patients' without a substantial segment of the small bowel or those with malnutrition syndrome (2). This condition usually develops as a result of surgical inter-of patients subjected to long-term parenteral nutrition, associated with the content of the nutritional mixture. The study is of retrospective character. The impact of the daily dose of glucose and glucose/lipid ratio were subjected to analysis, concerning the frequency of significant increased aminotransferases and bilirubin activity.
MATERIAL AND METHODS

Material
During the period between 2005 and 2012, 119 patients were subjected to parenteral nutrition at home, under the supervision of the Center for Nutritional Treatment, I Chair and Department of General, Transplantation, and Nutritional Treatment, Medical University in Lublin. All patients were subjected to analysis. Patients with diagnosed potential causes of hepatic disturbances, other than parenteral nutrition-dependent liver disease, as well as those with increased bilirubin and aminotransferases levels at the beginning of treatment (n=49 patients), were excluded from the study. The study group comprised 70 patients, including 38 women and 32 men. Mean age amounted to 51.8 years (ranging between 1-80 years). The most common diagnosis was as follows: malnutrition, due to neoplastic disease (n=39), short bowel syndrome (n=24) and others (n=7). During the analysed study period liver insufficiency was not observed. In case of patients with diagnosed cancer the tumor was located in the stomach, colon, ovaries, and pancreas. Short bowel syndrome was caused by mesenteric artery embolism, abdominal cavity injury, postoperative complications, and Crohn's disease. The average duration of treatment was 16 months, depending on the diagnosis: 8.8 months in case of carcinoma, 28.3 months in case of short bowel syndrome, and 10.4 months in remaining patients.
Methods
Analysis of control examination results performed every 3 months was undertaken. Each was aimed at the evaluation of the tolerance of treatment and eventual modification of the administered nutritional mixture. Liver vention (mesenteric vascular emboli or thrombosis), or after postoperative surgical complications. Oral nutrition in such cases is impossible or ineffective (3) . Treatment is therefore related to surgical departments, both at the beginning of therapy and onwards. Nutritional therapy centers at home are usually run by surgeons, being responsible for patient care by means of the following: proper insertion of a vascular port for the supply of the nutritional mixture, catheter control, nutritional control, and modification of nutritional doses, depending on the patients' demand and clinical course of treatment.
Despite the progress which has been made in total parenteral nutrition, many significant complications remain to be eliminated (4) . These complications are associated with the vascular port (thrombotic, septic, mechanical) or improper choice of nutritional mixture doses, proportions between their contents, improper therapeutic monitoring, as well as an inadequate diet adjusted to the patients' underlying disease (5, 6).
The main objective of nutritional therapy is to provide a sufficient quantity and quality of protein (amino-acids). However, without adequate non-protein energy supply the proper clinical effect will not be attained. The extra-protein energy is obtained from glucose and lipids. An important aspect of the abovementioned is to properly balance the source of energy so that the clinical effect (malnutrition compensation) does not lead to complications associated with glucose administration (7) and lipid emulsion (intensification of malnutrition).
During long-term parenteral nutrition treatment the occurrence of liver complications is a common problem (8) . They may take a very mild form, manifested by increased transaminases activity or increased bilirubin level. They may also lead to liver insufficiency. The clinical picture depends on the moment of diagnosis. The non-modification of the nutritional mixture might lead to the intensification of symptoms.
Hepatic complications have been known since the beginning of parenteral therapy. Most Authors associate their appearance with the too high daily dose of lipids. However, no one explicitly pointed to the cause responsible for these complications (9) .
The aim of the study was to determine factors leading to hepatic complications in case disturbances dependent of parenteral nutrition were defined as the increase of the total bilirubin level >1.2 mg/dl, and aminotransferases: AspAt and AlAt >50 IU/L. In such cases the nutritional mixture required modification, which often resulted in the improvement of control results. The persistent increase of liver enzymes required further diagnostics, in order to determine other reasons responsible for hepatic dysfunction. In order to determine factors which might have influence on the occurrence of hepato-biliary complications during consecutive treatment periods, the daily glucose, lipid, and non-protein energy, as well as the glucose/lipid ratio, were determined. The duration of treatment with a given nutritional mixture, which ended in control examinations was considered as the basic factor during comparative analysis. Treatment, after which lab results showed increased complete bilirubin and aminotransferases activity levels were allocated to the group with complications, while in case of no lab result abnormalities, to the group without complications. Such management enabled to increase the number of statistic calculations by increasing the number of analysed data (271 therapeutic periods).
For statistical analysis treatment periods were assigned to four groups. Group "A" analysis was based on aminotransferases activity, while group "B" on the basis of the bilirubin level. Both groups "A" and "B" were divided into group "I" with normal control lab values, and group "II" with increased bilirubin and aminotransferases levels. Group IA -normal AspAt and AlAt activity; group IIA -AspAt and AlAt >50IU/L. Group IIB-normal bilirubin level, and group IIB-increased bilirubin level (>1.2 mg/dl).
Statistical analysis
The STATISTICA 10 program (StatSoft, Poland) was used for statistical analysis. Difference analysis was based on the u ManWhitney test. The compliance distribution of analysed variables was undertaken with the use of Shapiro-Wilk and Kołmogorow-Smirnow tests. The correlation coefficients were calculated. p<0.05 was considered as statistically significant showing significant group differences.
RESULTS
Influence of selected parameters on aminotransferases values
The mean aminotransferase activity in groups Ia (n=169 observations) vs IIa (n=102 observations) amounted to AlAt -24.87 IU/l (ranging between 6-49 IU/l) vs 109.23 IU/l (52-512 IU/l), AspAt -25.84 IU/l (11-49 IU/l) vs 78.79 IU/l (54-296 IU/l), and mean bilirubin level -0.63 mg/dl (0.10-2.69 mg/dl) vs 1.50 mg/ dl (0.10-12.90 mg/dl).
No significant differences were observed between the study groups, considering the daily supply of lipids: group Ia -mean 0.70 g/ kg bw/daily (ranging between 0-2.38 g/kg bw/ daily), group IIa -0.75 g/kg bw/daily (0-2.07 g/kg bw/daily); (p=0.4). Statistically significant group differences were observed in case of the daily glucose supply (p=0.000003). Table 1 presented precise data.
Influence of selected parameters on the level of bilirubin
The mean level of bilirubin in groups Ib (n=222 observations) vs IIb (n=49 observations) amounted to 0.54 mg/dl (ranging between 0.10-1.10 mg/dl) vs 2.83 mg/dl (1.30-12.90 mg/dl), while the mean aminotransferases levels were as follows: AlAt -50.54 IU/l (6-512 IU/l) vs 85 IU/l (8-247 IU/l), AspAt -40.28 IU/l (11-296 IU/l) vs 71.18 IU/l (13-175 IU/l). No significant differences were observed between the study groups, considering the daily lipid supply: group Ib -mean 0.73 g/kg bw/daily (ranging between 0-2.38 g/kg bw/ daily), group IIb -0.70 g/kg bw/daily (0.00-2.07 g/kg bw/daily); (p=0.7). Statistically significant differences were observed in case of the daily glucose supply (p=0.0007), glucose/lipids ratio (p=0.01), and daily non-protein energy (p=0.04). Table 2 presented precise data.
DISCUSSION
Total parenteral nutrition is administered intravenously, which influences biochemical where the glucose/lipid ratio is increased. During periods of increased aminotransferase activity and bilirubin levels patients received nutritional mixtures with an increased glucose/lipid ratio (group IIa -4.90 g/kg bw/ daily, group IIb -5.13 g/kg bw/daily), as compared to periods where the above-mentioned parameters were within normal limits (group Ia -3.76 g/kg bw/daily, group Ib -3.98 g/kg bw/daily). A similar increase in the average glucose/lipid supply was observed in both patient groups with hepato-biliary complications. The observed dependency also concerned total extra-protein energy. In case of total parenteral nutrition the maintenance of a proper glucose/lipid ratio has been underlined by other authors (14) . Based on our observations we noted that the normalization of lab results consisted in the reduction of the glucose level, considering the nutritional mixture, as well as change in the glucose/ lipid proportion.
In case of observed liver abnormalities during control examinations, the nutritional mixture was subjected to modification, consisting in the reduction of the lipid content, which was consistent with the generally prevailing view (15). Considering parenteral nutrition in our center, industrial, two-and three-chamber nutritional bags are used. The modification of the nutritional mixture was associated with the exchange of one bag for another, which resulted in the change of the lipid content, as result abnormalities, since the human organism is devoid of the absorption of selected elements (10) .
Harmful long-term complications of parenteral nutrition, include liver diseases parenteral nutrition-dependent (PNALD) (11) . Early change in the proportions of nutritional mixtures might protect the patient from more pronounced hepato-biliary complications (12) . The nutritional mixture change consists in the reduction of the lipid emulsion content, which is considered responsible for these complications (13) .
Based on the obtained results (tab. 1) it was found that the average glucose supply in group Iia amounted to 3.49 g/kg bw/daily, which is higher, as compared to the mean supply in group Ia -2.52 g/kg bw/daily. Group IIa values ranged between 0.53 -11.02 g/kg bw/daily. The daily glucose supply (tab. 2) in groups Ib and IIb shows a similar dependency. In case of group IIb patients, the mean glucose supply was 3.46 g/kg bw/daily, which was higher in comparison to group Ib values-2.76 g/kg bw/daily. Differences were statistically significant. The differences in the supply of glucose suggest that its increase in the content of the nutritional mixture might be responsible for the occurrence of hepatic complications-increased bilirubin level and aminotransferases activity. The above-mentioned observation was confirmed by the fact that liver disturbances appeared in the group well as that of other elements. In most cases, such a change lead to the regression of abovementioned disturbances. Retrospective analysis showed that the reduction in lipid and glucose supply, as well as change in the proportions of extra-protein energy (glucose/lipid ratio) resulted in a positive clinical effectnormalization of aminotransferase activity and bilirubin level. Unfortunately, during shortterm treatment the dominating trend consists in the caloric increase of the nutritional mixture, primarily by increasing the glucose content (16). This is probably associated with the numerous liver complications (17) . In case of short-term treatment the occurrence of complications differs from the mechanism observed in case of long-term therapy (18). Analysis showed that the above-mentioned tendency is unfavorable.
CONCLUSIONS
Based on obtained results we were able to conclude that in case of liver complications associated with parenteral nutrition, proper management consists in the modification of nutritional mixtures (reduction in the daily glucose supply and change in the proportions of extra-protein energy). Such management has the greatest clinical effect. When determining the composition of the nutritional mixture one should adjust the glucose supply, so as to offset both sources of extra-protein energy.
